Matches in SemOpenAlex for { <https://semopenalex.org/work/W4223541971> ?p ?o ?g. }
- W4223541971 endingPage "4262" @default.
- W4223541971 startingPage "4262" @default.
- W4223541971 abstract "Parkinson's disease (PD) is a progressive neurodegenerative motor disorder without an available therapeutic to halt the formation of Lewy bodies for preventing dopaminergic neuronal loss in the nigrostriatal pathway. Since oxidative-stress-mediated damage has been commonly reported as one of the main pathological mechanisms in PD, we assessed the efficacy of a novel NOX inhibitor from AptaBio Therapeutics (C-6) in dopaminergic cells and PD mouse models. The compound reduced the cytotoxicity and enhanced the cell viability at various concentrations against MPP+ and α-synuclein preformed fibrils (PFFs). Further, the levels of ROS and protein aggregation were significantly reduced at the optimal concentration (1 µM). Using two different mouse models, we gavaged C-6 at two different doses to the PD sign-displaying transgenic mice for 2 weeks and stereotaxically PFF-injected mice for 5 weeks. Our results demonstrated that both C-6-treated mouse models showed alleviated motor deficits in pole test, hindlimb clasping, crossbeam, rotarod, grooming, and nesting analyses. We also confirmed that the compound treatment reduced the levels of protein aggregation, along with phosphorylated-α-synuclein, in the striatum and ventral midbrain and further dopaminergic neuronal loss. Taken together, our results strongly suggest that NOX inhibition can be a potential therapeutic target for PD." @default.
- W4223541971 created "2022-04-15" @default.
- W4223541971 creator A5012050880 @default.
- W4223541971 creator A5012718578 @default.
- W4223541971 creator A5014598778 @default.
- W4223541971 creator A5027710049 @default.
- W4223541971 creator A5038181988 @default.
- W4223541971 creator A5040205251 @default.
- W4223541971 creator A5049969297 @default.
- W4223541971 creator A5064534768 @default.
- W4223541971 creator A5065991900 @default.
- W4223541971 creator A5074153974 @default.
- W4223541971 creator A5083101453 @default.
- W4223541971 date "2022-04-12" @default.
- W4223541971 modified "2023-10-14" @default.
- W4223541971 title "A Novel NOX Inhibitor Treatment Attenuates Parkinson’s Disease-Related Pathology in Mouse Models" @default.
- W4223541971 cites W1170915589 @default.
- W4223541971 cites W1431164860 @default.
- W4223541971 cites W1500418512 @default.
- W4223541971 cites W1527671059 @default.
- W4223541971 cites W1588992136 @default.
- W4223541971 cites W1596038879 @default.
- W4223541971 cites W1889485241 @default.
- W4223541971 cites W1995994561 @default.
- W4223541971 cites W2009740169 @default.
- W4223541971 cites W2012647595 @default.
- W4223541971 cites W2016883839 @default.
- W4223541971 cites W2020319663 @default.
- W4223541971 cites W2021389999 @default.
- W4223541971 cites W2025922492 @default.
- W4223541971 cites W2052341819 @default.
- W4223541971 cites W2052894007 @default.
- W4223541971 cites W2054790952 @default.
- W4223541971 cites W2063747608 @default.
- W4223541971 cites W2064132577 @default.
- W4223541971 cites W2072125447 @default.
- W4223541971 cites W2075793841 @default.
- W4223541971 cites W2076598575 @default.
- W4223541971 cites W2080949995 @default.
- W4223541971 cites W2081389620 @default.
- W4223541971 cites W2082298489 @default.
- W4223541971 cites W2083228863 @default.
- W4223541971 cites W2085128107 @default.
- W4223541971 cites W2086857730 @default.
- W4223541971 cites W2087848764 @default.
- W4223541971 cites W2095239764 @default.
- W4223541971 cites W2104889897 @default.
- W4223541971 cites W2107434243 @default.
- W4223541971 cites W2107509703 @default.
- W4223541971 cites W2131710583 @default.
- W4223541971 cites W2132710428 @default.
- W4223541971 cites W2152165298 @default.
- W4223541971 cites W2161948816 @default.
- W4223541971 cites W2162583612 @default.
- W4223541971 cites W2164887435 @default.
- W4223541971 cites W2169324918 @default.
- W4223541971 cites W2185348657 @default.
- W4223541971 cites W2296299148 @default.
- W4223541971 cites W2582728366 @default.
- W4223541971 cites W2586895236 @default.
- W4223541971 cites W2612292118 @default.
- W4223541971 cites W2768638419 @default.
- W4223541971 cites W2771059099 @default.
- W4223541971 cites W2782358406 @default.
- W4223541971 cites W2787177558 @default.
- W4223541971 cites W2800058412 @default.
- W4223541971 cites W2963234188 @default.
- W4223541971 cites W2968033626 @default.
- W4223541971 cites W2975170802 @default.
- W4223541971 cites W3083404888 @default.
- W4223541971 cites W3179015401 @default.
- W4223541971 cites W658341232 @default.
- W4223541971 doi "https://doi.org/10.3390/ijms23084262" @default.
- W4223541971 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35457082" @default.
- W4223541971 hasPublicationYear "2022" @default.
- W4223541971 type Work @default.
- W4223541971 citedByCount "5" @default.
- W4223541971 countsByYear W42235419712022 @default.
- W4223541971 countsByYear W42235419712023 @default.
- W4223541971 crossrefType "journal-article" @default.
- W4223541971 hasAuthorship W4223541971A5012050880 @default.
- W4223541971 hasAuthorship W4223541971A5012718578 @default.
- W4223541971 hasAuthorship W4223541971A5014598778 @default.
- W4223541971 hasAuthorship W4223541971A5027710049 @default.
- W4223541971 hasAuthorship W4223541971A5038181988 @default.
- W4223541971 hasAuthorship W4223541971A5040205251 @default.
- W4223541971 hasAuthorship W4223541971A5049969297 @default.
- W4223541971 hasAuthorship W4223541971A5064534768 @default.
- W4223541971 hasAuthorship W4223541971A5065991900 @default.
- W4223541971 hasAuthorship W4223541971A5074153974 @default.
- W4223541971 hasAuthorship W4223541971A5083101453 @default.
- W4223541971 hasBestOaLocation W42235419711 @default.
- W4223541971 hasConcept C102230213 @default.
- W4223541971 hasConcept C104317684 @default.
- W4223541971 hasConcept C126322002 @default.
- W4223541971 hasConcept C137183658 @default.
- W4223541971 hasConcept C141035611 @default.
- W4223541971 hasConcept C169760540 @default.